Table 2.
Association Between SLC35F2 Expression and Clinicopathological Variables in BC Patients
| Characteristics | SLC35F2 Expression | Chi-Square | P Value | |
|---|---|---|---|---|
| Low (%); n=82 | High (%); n=83 | |||
| Invasiveness | ||||
| Superficial | 58 (70.3) | 45 (54.2) | 4.796 | 0.029 |
| Invasive | 24 (29.3) | 38 (45.8) | ||
| Gender | ||||
| Female | 14 (17.1) | 16 (19.3) | 0.135 | 0.714 |
| Male | 68 (82.9) | 67 (80.7) | ||
| Systemic chemo | ||||
| Yes | 10 (12.2) | 17 (20.5) | 2.070 | 0.150 |
| No | 72 (87.8) | 66 (79.5) | ||
| Grade | ||||
| High | 27 (32.93) | 33 (39.76) | 0.832 | 0.362 |
| Low | 55 (67.07) | 50 (60.24) | ||
| T stage | ||||
| Ta-T1 | 59 (72.0) | 45 (54.2) | 5.567 | 0.018 |
| T2-T4 | 23 (28.0) | 38 (45.8) | ||
| M stage | ||||
| M0 | 78 (95.1) | 80 (96.4) | 0 | 0.987 |
| M1 | 4 (4.9) | 3 (3.61) | ||
| N stage | ||||
| N0 | 75 (92.6) | 74 (89.2) | 0.582 | 0.445 |
| N1-N3 | 6 (7.4) | 9 (10.8) | ||